Soru

Zorluk: ZorDepressive Disorders

A 3131-year-old man presents via telehealth for an initial psychiatric evaluation. He reports a 77-week history of persistent low mood, extreme lethargy, and a 66-kg (1313-lb) weight gain. He sleeps up to 1515 hours a day and describes his limbs as feeling 'unnaturally heavy.' For the past 22 weeks, he has also been hearing a distinct, critical voice telling him he is 'toxic and contagious' whenever he is alone in his room. Upon detailed psychiatric history taking, he reveals that 33 years ago, he was hospitalized for a 1010-day period during which he believed he was a divine messenger, slept only 11 hour per night, and paced the streets preaching. He was stabilized and discharged but stopped his prescribed medications shortly afterward. He recently began taking a high-dose over-the-counter St. John's wort supplement to improve his mood, but it has provided no relief. A recent primary care blood panel shows a thyroid-stimulating hormone (TSH) level of 2.12.1 mU/L (normal: 0.50.5-5.05.0) and a free thyroxine (T4) level of 1.11.1 ng/dL (normal: 0.80.8-1.81.8). Which of the following is the most appropriate next step in the management of this patient?

  1. Discontinue St. John's wort and initiate quetiapineCevap
  2. B
    Discontinue St. John's wort and initiate fluoxetine monotherapy
  3. C
    Add phenelzine to his current supplement regimen
  4. D
    Diagnose schizophreniform disorder and initiate haloperidol
  5. E
    Initiate levothyroxine therapy to correct underlying metabolic dysfunction

Cevap

The most appropriate next step is to discontinue St. John's wort and initiate quetiapine.
The patient is presenting with a major depressive episode characterized by atypical features (hypersomnia, hyperphagia, leaden paralysis) and psychotic features (auditory hallucinations). Crucially, his history of a 1010-day hospitalization for grandiosity and decreased sleep confirms a diagnosis of Bipolar I Disorder. The most appropriate treatment for acute bipolar depression with psychotic features is an atypical antipsychotic that has demonstrated efficacy in bipolar depression, such as quetiapine or lurasidone. Quetiapine provides both mood-stabilizing effects for the bipolar depression and dopamine antagonism to treat the active psychosis. Additionally, the patient's over-the-counter St. John's wort should be discontinued due to lack of efficacy and a high risk of dangerous pharmacokinetic interactions (it is a potent CYP3A4 inducer and serotonergic agent).

Adım Adım Çözüm

1
Analyze the current clinical presentation.
The patient presents with an acute major depressive episode characterized by atypical features (hypersomnia, weight gain, leaden paralysis) and mood-congruent psychotic features (auditory hallucinations for 22 weeks).
Identifying the current symptom cluster dictates the immediate therapeutic targets.
2
Evaluate the past psychiatric and medical history.
A previous hospitalization for a 1010-day episode of severe grandiosity, lack of sleep, and impaired functioning defines a prior manic episode. The thyroid panel is normal.
A history of mania changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder, fundamentally altering the pharmacologic algorithm and ruling out unipolar depression and organic causes.
3
Determine the optimal pharmacotherapy while avoiding drug interactions.
St. John's wort must be discontinued due to inefficacy and interaction risks. Quetiapine is selected as it is approved for bipolar depression and provides D2 blockade for his psychotic features.
Monotherapy with traditional antidepressants must be avoided in bipolar depression. An atypical antipsychotic covers both the mood and psychotic symptoms safely.

Anahtar Kavram

Bipolar I Disorder, Current Episode Depressed with Psychotic and Atypical Features
Tahmini Süre:1m 30s
Bu soruyu puanla